ExeGi Pharma, LLC.
Marc Tewey has a diverse work experience spanning over several industries. Marc is currently serving as the Chief Executive Officer of ExeGi Pharma, a biotechnology company focused on the development and commercialization of live biotherapeutic and probiotic medicines. Prior to their current role, Marc was also the Chief Executive Officer at Cambrooke Therapeutics, a global leader in advanced medical nutrition. Additionally, they were the Vice President of Commercial Operations at Cerium Pharmaceuticals, a biopharmaceutical company specializing in medicines for rare diseases. Marc has also held various roles at Sigma-Tau Pharmaceuticals, including VP of Commercial Operations, Sr. Director of Commercial Development, Director of Consumer Health Products, and Director of Sales. Marc has prior experience in sales and key account management at Pepsi Bottling Group and owns Brimstone Brewing Company, where they served as the Owner and Brewmaster. throughout their career, Marc has demonstrated expertise in commercial operations, strategy development, and project management.
Marc Tewey has a BA/MBA degree from Loyola University Maryland, which they obtained between 1988 and 1992. Marc also holds an MBA degree with a focus on Business from Loyola University Maryland, earned from 2000 to 2003.
This person is not in any teams
ExeGi Pharma, LLC.
ExeGi Pharma is a biotechnology company focused on the development and commercialization of live biotherapeutic and probiotic medicines. Our team leverages the field of microbiome science to deliver novel, clinically supported, live biotherapeutic and probiotic treatments for a variety of unmet medical needs for both humans and veterinary applications. Makers of Visbiome and Visbiome Vet high potency probiotics.